Egypt becomes the first country to achieve WHO validation on the path to elimination of ...
9 October 2023, Cairo, Egypt – The World Health Organization (WHO) congratulates Egypt for its unprecedented progress towards eliminating hepatitis C, becoming the first country to achieve “gold tier” status on the path to elimination of hepatitis C as per WHO criteria. Achieving the gold tier means that Egypt has fulfilled the programmatic requirements that facilitate the reduction of new hepatitis C infections and deaths to levels that position the country to end the hepatitis C epidemic.
Globally, 58 million people are living with chronic hepatitis C infection. While there is no vaccine, the disease can be cured ...
Source: WHO EMRO News - October 9, 2023 Category: Middle East Health Source Type: news
Early-Onset NAFLD Tied to Higher Cancer Risk Early-Onset NAFLD Tied to Higher Cancer Risk
Earlier age at onset of nonalcoholic fatty liver disease was associated with an increased risk for cancer, mainly digestive and lung cancers, in a large cohort study.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - October 4, 2023 Category: Cancer & Oncology Tags: Gastroenterology News Source Type: news
Washington Post Article Brings Attention to Pediatric NAFLD and How C15:0 May Help Tackle the Alarming Rise in this Liver Disease
The Washington Post releases an article on rise in liver disease. SAN DIEGO, Oct. 3, 2023 /PRNewswire-PRWeb/ -- Today, The Washington Post spotlights the alarming rise of nonalcoholic fatty liver disease (also called NAFLD) in kids and how C15:0 may help transform the battle against this... (Source: PRWeb: Medical Pharmaceuticals)
Source: PRWeb: Medical Pharmaceuticals - October 3, 2023 Category: Pharmaceuticals Tags: SVY CHI DEI Source Type: news
10 Questions Answered About New Liver Disease Term'MASLD'10 Questions Answered About New Liver Disease Term'MASLD '
Dr William Balistreri on the reasons why an international panel is phasing out NAFLD/NASH.Medscape Gastroenterology (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - September 28, 2023 Category: Consumer Health News Tags: Gastroenterology Commentary Source Type: news
Cancer Risk in NAFLD Higher With Early Disease Onset
(MedPage Today) -- The risk for cancer in patients with nonalcoholic fatty liver disease (NAFLD) was highest among those with early-onset disease and declined at later ages of diagnosis, a matched cohort study found.
Examining more than 60,000... (Source: MedPage Today Gastroenterology)
Source: MedPage Today Gastroenterology - September 28, 2023 Category: Gastroenterology Source Type: news
Protein that drives liver damage could be a target for treatment
Yale researchers have identified a protein that drives symptoms of severe liver disease and may be a target for treatment in the future. (Source: Yale Science and Health News)
Source: Yale Science and Health News - September 27, 2023 Category: Universities & Medical Training Source Type: news
Protein that drives liver damage could be a new target for treatment
Yale researchers have identified a protein that drives symptoms of severe liver disease and may be a target for treatment in the future. (Source: Yale Science and Health News)
Source: Yale Science and Health News - September 27, 2023 Category: Universities & Medical Training Source Type: news
‘I'm a doctor - here are some red flag symptoms of fatty liver disease to look for’
If not treated, fatty liver disease can cause liver failure and even death. (Source: Daily Express - Health)
Source: Daily Express - Health - September 25, 2023 Category: Consumer Health News Source Type: news
Income inequality and 'hospitalisations of despair' in Canada: a study on longitudinal, population-based data - Benny C, Siddiqi A, Pabayo R.
BACKGROUND: Rates of drug overdoses, alcohol-related liver disease and suicide attempts represent a major public health burden in Canada. While the existing literature does highlight some evidence of association between income inequality and mental health ... (Source: SafetyLit)
Source: SafetyLit - September 25, 2023 Category: International Medicine & Public Health Tags: Alcohol and Other Drugs Source Type: news
Wine o'clock could be DEADLY: Liver disease rates have shot up five-fold since the 70s - and experts fear heavy evening drinking may be to blame
Experts said findings should serve as a 'wakeup call' to change lifestyle factors associated with the disease - namely alcohol and obesity - and called for more liver ultrasounds for early detection. (Source: the Mail online | Health)
Source: the Mail online | Health - September 21, 2023 Category: Consumer Health News Source Type: news
AGA CPU Focuses on Noninvasive Tests in Patients With NAFLD AGA CPU Focuses on Noninvasive Tests in Patients With NAFLD
Noninvasive testing allows for routine risk stratification and long-term monitoring of patients with nonalcoholic fatty liver disease, offering a safer, more practical approach than biopsy.MDedge News (Source: Medscape Gastroenterology Headlines)
Source: Medscape Gastroenterology Headlines - September 20, 2023 Category: Gastroenterology Tags: Gastroenterology News Source Type: news
Five red flag signs of liver disease that can be spotted on your face, doctor shares
Symptom awareness with fatty liver disease is crucial as early detection could stop the condition from progressing to liver scarring and failure. (Source: Daily Express - Health)
Source: Daily Express - Health - September 17, 2023 Category: Consumer Health News Source Type: news
Why CymaBay, With 159% Growth This Year, Just Surged For A Second Day Running
Shares of CBAY stock surged for a second day Friday as analysts compared CymaBay Therapeutics' (CBAY) experimental liver-disease treatment to rivals from Intercept Pharmaceuticals (ICPT) and Genfit (GNFT). The company tested its drug in patients with primary biliary cholangitis, a chronic…#cbay #cymabaytherapeutics #cymabay #intercept #ocaliva #genfit #leerinkpartners #thomassmith #bullishly #notably (Source: Reuters: Health)
Source: Reuters: Health - September 9, 2023 Category: Consumer Health News Source Type: news
NAFLD Raises Risk for Colorectal Adenomatous Polyps NAFLD Raises Risk for Colorectal Adenomatous Polyps
Nonalcoholic fatty liver disease was associated with a higher risk for colorectal adenomatous polyps in men and women in a study from China.Medscape Medical News (Source: Medscape Gastroenterology Headlines)
Source: Medscape Gastroenterology Headlines - September 8, 2023 Category: Gastroenterology Tags: Gastroenterology News Source Type: news
Sweetened Drinks Are Linked to Chronic Liver Disease And Liver Cancer
Authored by Flora Zhao via The Epoch Times (emphasis ours), Do you find yourself drinking a sweetened beverage every day? Be cautious, as this habit could increase the risk of chronic liver disease and even liver cancer. It is…#florazhao #epochtimes (Source: Reuters: Health)
Source: Reuters: Health - September 1, 2023 Category: Consumer Health News Source Type: news
